Pediatric high-grade glioma: biologically and clinically in need of new thinking

C Jones, MA Karajannis, DTW Jones… - Neuro …, 2017 - academic.oup.com
High-grade gliomas in children are different from those that arise in adults. Recent
collaborative molecular analyses of these rare cancers have revealed previously …

[HTML][HTML] Molecular pathology of tumors of the central nervous system

BW Kristensen, LP Priesterbach-Ackley, JK Petersen… - Annals of oncology, 2019 - Elsevier
Since the update of the 4th edition of the WHO Classification of Central Nervous System
(CNS) Tumors published in 2016, particular molecular characteristics are part of the …

[HTML][HTML] Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups

KW Pajtler, H Witt, M Sill, DTW Jones, V Hovestadt… - Cancer cell, 2015 - cell.com
Ependymal tumors across age groups are currently classified and graded solely by
histopathology. It is, however, commonly accepted that this classification scheme has limited …

Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord

Y Wang, S Springer, M Zhang… - Proceedings of the …, 2015 - National Acad Sciences
Cell-free DNA shed by cancer cells has been shown to be a rich source of putative tumor-
specific biomarkers. Because cell-free DNA from brain and spinal cord tumors cannot …

2016 updates to the WHO brain tumor classification system: what the radiologist needs to know

DR Johnson, JB Guerin, C Giannini, JM Morris… - Radiographics, 2017 - pubs.rsna.org
Radiologists play a key role in brain tumor diagnosis and management and must stay
abreast of developments in the field to advance patient care and communicate with other …

[HTML][HTML] Oligodendroglioma: pathology, molecular mechanisms and markers

P Wesseling, M van den Bent, A Perry - Acta neuropathologica, 2015 - Springer
For nearly a century, the diagnosis and grading of oligodendrogliomas and
oligoastrocytomas has been based on histopathology alone. Roughly 20 years ago, the first …

A biobank of patient-derived pediatric brain tumor models

S Brabetz, SES Leary, SN Gröbner, MW Nakamoto… - Nature medicine, 2018 - nature.com
Brain tumors are the leading cause of cancer-related death in children. Genomic studies
have provided insights into molecular subgroups and oncogenic drivers of pediatric brain …

The developmental origin of brain tumours: a cellular and molecular framework

R Azzarelli, BD Simons, A Philpott - Development, 2018 - journals.biologists.com
The development of the nervous system relies on the coordinated regulation of stem cell self-
renewal and differentiation. The discovery that brain tumours contain a subpopulation of …

Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy

C Cacciotti, A Fleming… - The Journal of pathology, 2020 - Wiley Online Library
Central nervous system (CNS) tumors are the most common solid tumor in pediatrics,
accounting for approximately 25% of all childhood cancers, and the second most common …

Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II …

AS Levy, M Krailo, S Chi, D Villaluna… - Pediatric blood & …, 2021 - Wiley Online Library
Background: Approximately 30% of children with medulloblastoma (MB) experience
recurrence, which is usually incurable. This study compared the overall survival (OS) of …